Earnings
The "New Vice" Economy: 5 Stocks Profiting from the Shift to Clean Fuel

MOOD · Price
Executive Summary
- The release highlights a broad consumer shift toward functional wellness products, positioning several companies—including Doseology Sciences, Philip Morris International, Canopy Growth, Zevia, and Lifeway Foods—for growth.
- Material corporate actions are disclosed: Doseology’s acquisition of Feed That Brain for $400k in securities and its new manufacturing agreement; Zevia’s Q3‑2025 financial results showing a 12.3% sales increase; PMI’s expanded ZYN branding partnership with Scuderia Ferrari HP; Canopy Growth’s launch of high‑THC “Claybourne Gassers” vapes; Lifeway Foods’ recognition on Inc.’s Best Challenger Brands list.
- These updates collectively indicate positive momentum across the wellness and smoke‑free product sectors, suggesting material upside for the highlighted companies.
Key Details
- Consumer Trend Insight: 46 million consumer mentions of health‑focused products; 41% of wellness spend driven by younger demographics (36% of adult population).
- Doseology Sciences Inc.
- Acquired Feed That Brain (Toronto health supplement brand) for $400,000 in securities; added strategic advisor Joseph Mimran with a three‑year advisory agreement valued at $400,000 in restricted share units.
- Secured a manufacturing agreement through wholly‑owned subsidiary Doseology USA Inc. to commence commercial production of caffeine, nicotine, and functional ingredient pouches.
- Launched an Investor Communications Initiative in early December 2025 to improve disclosure practices.
- Philip Morris International (PMI)
- Expanded partnership with Scuderia Ferrari HP & Ferrari Challenge Trofeo Pirelli for the 2026 season onward; ZYN nicotine‑pouch branding will appear on F1 liveries beginning at the Abu Dhabi Grand Prix 2025 (Dec 7).
- Smoke‑free products now represent 41% of PMI’s net revenues for the first nine months of 2025, up from 25% a year earlier.
- Canopy Growth Corporation
- Introduced “Claybourne Gassers,” an all‑in‑one vape line featuring 92–98% THC liquid diamonds in three flavors; includes digital display, variable voltage, anti‑burn/clog tech, USB‑C rechargeable format.
- Launched “Frosted Flyers” 8‑pack (0.35 g each) with 33–36% THC across top‑selling strains; available at licensed retail and select online stores.
- Zevia PBC
- Q3‑2025 net sales: $40.8 million (+12.3% YoY); volume growth 12.6%; gross profit margin 45.6% (down 3.5 pts YoY due to inventory losses and tariff impacts).
- Net loss: $2.8 million (including $0.9 million non‑cash equity compensation); Adjusted EBITDA loss: $1.7 million.
- Cash & equivalents at Sep 30 2025: ~$26.0 million; no debt; unused credit line $20 million.
- Lifeway Foods
- Named to Inc.’s 2025 “Best Challenger Brands” list (Best in Business).
- Recognized by TIME as a Growth Leader and awarded Dairy Foods’ Processor of the Year 2025.
Notable Quotes
- “Our strategy is clear: to lead innovation in the oral stimulant category with a sharp focus on speed to market and operational excellence.” – Chris Jackson, CEO, Doseology Sciences Inc.
- “PMI shares with Scuderia Ferrari HP the pursuit to innovate and challenge the status quo for millions of adults that share this passion.” – Stefano Volpetti, President Smoke‑Free Products & Chief Consumer Officer, PMI
- “Our strong performance in the third quarter… underscores our continued progress across our strategic growth pillars.” – Amy Taylor, CEO, Zevia PBC
- “Being recognized by Inc. is an incredible validation of our team's commitment to innovation and impact.” – Julie Smolyansky, CEO, Lifeway Foods
All information extracted from the news release; boilerplate disclaimer and advertising language omitted.
More from Doseology Sciences Inc.
Mar 11, 2026 · 16:48